首页> 中文期刊> 《湖南师范大学学报(医学版)》 >主动脉内球囊反搏在急性冠脉综合征患者中的临床应用

主动脉内球囊反搏在急性冠脉综合征患者中的临床应用

         

摘要

目的:分析和评价主动脉内球囊反搏(IABP)在急性冠脉综合征(ACS)患者辅助治疗中的临床疗效.方法:60例ACS患者在不同的病情及治疗状况下,给予IABP治疗,观察使用IABP前后患者心率、血压及NT-proBNP 的变化,注意IABP相关并发症,住院期间死亡情况.结果:60例患者接受IABP治疗后,血流动力学改善,其中合并心源性休克的患者在使用IABP后2h后血压即达到稳定状态,72 h后NT-proBNP值明显下降.IABP相关并发症5例,严重并发症0例,住院期间死亡12例,其中合并心源性休克死亡9例.结论:对于ACS尤其是合并血流动力学不稳定或心源性休克的患者,IABP可以安全的使用,并有效地稳定血流动力学状态,为患者争取进行血运重建的时间,减少患者急性期的死亡率,改善预后.%To analyze and evaluate the effective of intra-aortic balloon pumping (IABP) suppot in patients with acute conoary syndrome(ACS). Methods 60 patients with acute conoary syndrome were performed IABP under different condition and treatment status, observe the change of the blood pressure , heart rate and NT-proBNP level.Pay attention to the IABP-related complications and death during hospitalization. Results All the patients with IABP support , the hemodynamic parameters improved, and stabilized in the after 2 hours among the patients with cardiogenic shock, NT-proBNP level decreased obviously in the later 72 hours. IABP-related complications was only 5cases, no serious complications, 12 cases died in hospital, 3/4 complicated with cardiogenic shock. Conclusion IABP can be safe to use in the acs patients,especially with hemodynamic instability or cardiogenic shock,which can effectively stabilize the hemodynamic status, for patients to undergo revascularization time, reduce the mortality of patients with acute period, improve the prognosis.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号